Psychedelic News & Headlines #3
New Zealand opens a door and Italy slams one shut, while a quiet study asks whether the whole field has been overselling itself, as Hollywood gets deeper into…
What’s New in
Psychedelics — and Why
It Matters
Your source for psychedelic news, scientific breakthroughs, legal updates, and expert insights.
Weekly Digest
MindShift 101:Our curated digest,
every Friday in your inbox
The most important conversations shaping the future of psychedelics, delivered weekly.
Joined by 12,000+ readers
Latest
News
The FDA Just Held Its First Hearing on Psychedelic Medicine
Four hours at the FDA made it official: approving a psychedelic is the easy part. Everything that matters comes after.
Science
Can Psychedelic-Assisted Therapy Help With Severe Anxiety?
Which psychedelics actually have evidence for anxiety? We break it down with Floris Wolswijk, founder of research database Blossom.
Insights
EMDR Therapy in the UK, and How It Compares with Psychedelic Therapy
A clear look at EMDR in the UK: how it actually works, what it costs, how to find someone properly accredited, and how it compares with MDMA, psilocybin…
Insights
Can Non-Hallucinogenic Psychoplastogens Deliver the Therapeutic Signal?
Neuroplastogens promise psychedelics' brain-rewiring effects without the trip. But can plasticity alone deliver the therapeutic signal?
Science
Could Psychedelics Support Healthy Aging and Longevity?
Research into psychedelics for healthy aging is now being backed by millions of pounds.
News
Locked in Schedule 1. UK and the Psilocybin Question
A recent nationwide poll finds broad support for psilocybin-assisted therapy in the UK. But does reality match public opinion?
Science
Can Magic Mushrooms Help With Alzheimer’s?
A woman with advanced Alzheimer's regained memory, mobility, and self-care after two psilocybin sessions — a striking case, not yet clinical proof.
Science
Brain Changes After One Psilocybin Treatment
A single 25mg psilocybin dose increased brain entropy and reshaped white matter in 28 participants — changes still visible one month later, a new study finds.
Science
Psilocybin And Inflammation: A New Frontier In Psychedelics?
Psilocybin activates a receptor that suppresses inflammation, even at microdoses — Prof. Charles Nichols' team found. Evidence is preclinical, but promising.
Loading more stories...
Ready when you are
Free, private, and takes less than a minute.
